What is DADA2?

 

DADA2 — deficiency of the enzyme ADA2 (Adenosine Deaminase 2) — is a recently discovered and extremely rare genetic disease that usually starts in childhood. It can cause recurrent strokes, severe systemic inflammation, immune deficiency, and damage to many of the body's tissues and organs. 

 

Maja and Jonas Morell Thomsen tell the story of how finding the DADA2 Foundation saved their baby daughter's life. 


We're planning the 2nd International Conference on DADA2! here's a look back at our first meeting in 2016:


RESEARCH

The first paper describing DADA2 was published in the New England Journal of Medicine in 2014. Research groups in the United States, Finland, and Israel are studying the disease. 

Learn more →

 

PATIENT REGISTRY

We have learned from patient groups focused on other rare diseases that the most important first step is to gather information from as many patients as possible. Please help us!

Find out how →

CONFERENCE

In November, clinicians, researchers, and patients from around the world will meet for the second time in Bethesda, MD to plan a way forward for the diagnosis and treatment of DADA2. 

Find out more →

 

Join us ON FACEBOOK

Our group for patients, families, and friends is a good place to find support from families who may have been through similar experiences.

Come say hi